Marek Minárik

The dominant role of G12C over other KRAS mutation types in the negative prediction of efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer

2013 | Lékařská fakulta v Plzni

Publikace